These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3617164)

  • 1. A new radioimmunoassay of thioridazine and its comparison with a high performance liquid chromatographic method and another radioimmunoassay.
    Chakraborty BS; Hawes EM; Rosenthaler J; Midha KK
    Ther Drug Monit; 1987 Jun; 9(2):227-35. PubMed ID: 3617164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a radioimmunoassay procedure for sulforidazine and its comparison with a high-performance liquid chromatographic method.
    Chakraborty BS; Hawes EM; Midha KK
    Ther Drug Monit; 1988; 10(2):205-14. PubMed ID: 3381240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic method.
    Chakraborty BS; Hawes EM; Midha KK
    Ther Drug Monit; 1987 Dec; 9(4):464-71. PubMed ID: 3424415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnanogram quantitation of chlorpheniramine in plasma by a new radioimmunoassay and comparison with a liquid chromatographic method.
    Midha KK; Rauw G; McKay G; Cooper JK; McVittie J
    J Pharm Sci; 1984 Aug; 73(8):1144-7. PubMed ID: 6491921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice.
    Welp A; Manz B; Peschke E
    J Immunol Methods; 2010 Jun; 358(1-2):1-8. PubMed ID: 20363223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay and gas chromatography/mass spectrometry for a novel antiglaucoma medication of a prostaglandin derivative, S-1033, in plasma.
    Kominami G; Nakamura M; Mizobuchi M; Ueki K; Kuroda T; Yamauchi A; Takahashi S
    J Pharm Biomed Anal; 1996 Nov; 15(2):175-82. PubMed ID: 8933419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a specific and sensitive radioimmunoassay for trihexyphenidyl to a pharmacokinetic study in humans.
    He H; McKay G; Wirshing B; Midha KK
    J Pharm Sci; 1995 May; 84(5):561-7. PubMed ID: 7658345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of analysis of digoxin in cardiac patients by HPLC and RIA.
    Kwong E; Embree L; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):121-4. PubMed ID: 2345802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of ganirelix in plasma or serum.
    Nerenberg C; LaFargue J; Gee C; Chu F; Wolfe L; Chan R; Tarnowski T
    J Immunoassay; 1993 Sep; 14(3):191-207. PubMed ID: 8354719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
    Chapman DJ; Joel SP; Aherne GW
    J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of colchicine with antisera exhibiting variable cross-reactivity.
    Sabouraud A; Cano N; Scherrmann JM
    Ther Drug Monit; 1994 Apr; 16(2):179-85. PubMed ID: 8009567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of isepamicin in human plasma by radioimmunoassay, microbiologic assay, and high-performance liquid chromatography.
    Lin CC; Veals J; Korduba C; Hilbert MJ; Nomeir A
    Ther Drug Monit; 1997 Dec; 19(6):675-81. PubMed ID: 9421110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of detirelix ([ N-Ac-D-Nal(2)1,D-p-Cl-Phe2,D-Trp3, D-hArg(Et)6(2),D-Ala10]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C; LaFargue J; Webb A; Chan R; Kushinsky S
    J Immunoassay; 1988; 9(3-4):245-55. PubMed ID: 3069871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer.
    Vakkuri O; Leppäluoto J; Vuolteenaho O
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):152-7. PubMed ID: 6539551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological studies on delayed hypersensitivity to phenytoin--I. A new method for preparing phenytoin antiserum.
    Tasaka K; Terao R; Kamei C; Hashigaki K; Yamato M
    Int J Immunopharmacol; 1987; 9(3):391-9. PubMed ID: 3610423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C; Foreman J; Chu N; Chaplin MD; Kushinsky S
    Anal Biochem; 1984 Aug; 141(1):10-6. PubMed ID: 6238549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective HPLC/RIA for the determination of budesonide.
    Hochhaus G; Fröehlich P; Hochhaus R; Möllmann A; Derendorf H; Möllmann HW
    J Pharm Biomed Anal; 1998 Sep; 17(8):1235-42. PubMed ID: 9800642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPE/RIA vs LC/MS for measurement of low levels of budesonide in plasma.
    Dimova H; Wang Y; Pommery S; Moellmann H; Hochhaus G
    Biomed Chromatogr; 2003 Jan; 17(1):14-20. PubMed ID: 12583000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of a radioimmunoassay of the new progestagen gestodene.
    Nieuweboer B; Tack J; Täuber U; Hümpel M; Wendt H
    Contraception; 1989 Sep; 40(3):313-23. PubMed ID: 2766723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.